The Indian pharmaceutical and healthcare sector is set for growth with anticipated support from Union Budget 2025, focusing ...

The report sheds light on the sector's robust performance in FY24, with the Indian pharmaceutical market growing by nearly 9% ...

India Budget: There is high anticipation among the pharmaceutical and healthcare sectors that the Indian Union Budget 2025, which will be unveiled later this week, should support their need for ...

The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...

(HealthDay News) — There is an increase in psychotropic medication use and mental health service use around the time of prostate cancer diagnosis, according to a study published online July 3 in ...

Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine.

Better Access Australia chairwoman Felicity McNeill, a former head of the Pharmaceutical Benefits Scheme. Funding has also been restrained by lack of cost recovery within the PBAC system ...

Aggressive and misleading marketing is fuelling demand for medicinal cannabis. Here are some of the ways clinics bend the ...

India’s pharmaceutical sector gathers for national GMP conference at AMTZ: Our Bureau, Mumbai Thursday, January 23, 2025, 11:45 Hrs [IST] A national conference focusing on "Enha ...

In a new report, the ANAO deemed the Pharmaceutical Benefits Scheme, under which the PBAC operates, only “partly effective”, having consistently failed to meet performance requirements since 2022.

Jefferies analyst David Stanton maintained a Sell rating on Sigma Healthcare Ltd (S5YA – Research Report) on January 17 and set a price target ...

Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre said that they ...